XCUR Exicure, Inc.Stock Price & Overview
$0.750.0079 (+1.06%)1:31 PM 10/03/23
NASDAQ | $USD | Delayed
Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company’s preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.